Business Context and Reporting Period
This Form 8-K is filed by LabStyle Innovations Corp. (not Dariohealth Corp.) with a report date of October 10, 2014, covering an event that occurred on October 6, 2014. The filing details a corporate action regarding the company's capital structure.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The only quantitative data relates to share count adjustments:
- Pre-Split Outstanding Shares: Approximately 79.5 million
- Post-Split Outstanding Shares: Approximately 15.9 million
- Authorized Shares: 80 million (unchanged)
- Par Value: $0.0001 per share
Material Changes
On October 6, 2014, the Company effected a 1-for-5 reverse stock split. This action was approved by the Board of Directors under authority granted at the 2014 Annual Meeting of Stockholders on June 17, 2014, and consummated via a Certificate of Amendment filed with the Delaware Secretary of State on September 30, 2014. Fractional shares resulting from the split were rounded up to the next whole number.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a notification of the amendment to the Articles of Incorporation to implement the reverse split.
Investor Verification Checklist
- Verify the current trading symbol and share price post-split to ensure proper adjustment of holdings.
- Confirm the exact number of shares held after the rounding of fractional shares.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for specific legal terms of the split.
- Note that the filing entity is LabStyle Innovations Corp., not Dariohealth Corp.